BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 12526228)

  • 1. [Detection of serum tumor supplied group of factors and its clinical significance].
    Liang YR; Wan DS; Chen G; Lu ZH; Li YJ; Lin YH; Chi PD
    Ai Zheng; 2002 Nov; 21(11):1251-3. PubMed ID: 12526228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of detecting serum tumor supplied group of factors in differential diagnosis of neck masses].
    Kuang GQ; Yang RN; Mo LG
    Ai Zheng; 2002 Sep; 21(9):1002-4. PubMed ID: 12508551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of assaying tumor supplied group of factor/tumor specific growth factor in patients with solitary pulmonary nodule.
    Deng B; Tan QY; Fan XQ; Jiang YG; Zhao YP; Zhou JH; Liang YG; Wang RW
    Clin Lung Cancer; 2011 May; 12(3):192-6. PubMed ID: 21663863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.
    Ando E; Kuromatsu R; Tanaka M; Takada A; Fukushima N; Sumie S; Nagaoka S; Akiyoshi J; Inoue K; Torimura T; Kumashiro R; Ueno T; Sata M
    J Clin Gastroenterol; 2006; 40(10):942-8. PubMed ID: 17063116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical value of tumor-associated growth factor detection in the diagnosis of colorectal carcinoma].
    Yang J; Wang D
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Oct; 27(10):1577-9. PubMed ID: 17959542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic value of combined detection of CYFRA21-1 and TSGF in nasopharyngeal carcinoma].
    Huang L; Huang W; Chen Y
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Mar; 19(5):201-2. PubMed ID: 15934283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
    Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N
    Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urine diacetylspermine as a novel tumor marker].
    Yamaguchi K; Kaku T; Enjoji M; Kato M; Anai M; Kawakita M; Hamasaki N; Tanaka M
    Rinsho Byori; 2005 Feb; 53(2):130-5. PubMed ID: 15796046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection.
    Marrelli D; Roviello F; De Stefano A; Fotia G; Giliberto C; Garosi L; Pinto E
    J Am Coll Surg; 2004 Jan; 198(1):51-8. PubMed ID: 14698311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma.
    Sun HC; Zhang W; Qin LX; Zhang BH; Ye QH; Wang L; Ren N; Zhuang PY; Zhu XD; Fan J; Tang ZY
    J Hepatol; 2007 Nov; 47(5):684-90. PubMed ID: 17854945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of Golgi glycoprotein 73, a new tumor marker in diagnosis of hepatocellular carcinoma: a primary study].
    Mao YL; Yang HY; Xu HF; Sang XT; Lu X; Yang ZY; Zhang JC; Zhong SX; Huang JF; Zhang HB
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):948-51. PubMed ID: 18756964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of plasma D-dimer levels and serum VEGF levels in patients with hepatocellular carcinoma.
    Tseng CS; Lo HW; Chen PH; Chuang WL; Juan CC; Ker CG
    Hepatogastroenterology; 2004; 51(59):1454-8. PubMed ID: 15362775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid kinetic rate assay of the serum alpha-L-fucosidase in patients with hepatocellular carcinoma by using a novel substrate.
    Wang JJ; Cao EH
    Clin Chim Acta; 2004 Sep; 347(1-2):103-9. PubMed ID: 15313147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma.
    Miura N; Maeda Y; Kanbe T; Yazama H; Takeda Y; Sato R; Tsukamoto T; Sato E; Marumoto A; Harada T; Sano A; Kishimoto Y; Hirooka Y; Murawaki Y; Hasegawa J; Shiota G
    Clin Cancer Res; 2005 May; 11(9):3205-9. PubMed ID: 15867214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical value of tumor supplied group of factor combined with CEA in diagnosing tuberculosis pleural effusion and malignant pleural effusion].
    Li YP; Hu CP; Yang HZ
    Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):608-10. PubMed ID: 15804072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
    Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
    Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of serum cytokeratin-19 fragment (CYFRA 21-1) in hepatocellular carcinoma.
    Uenishi T; Yamazaki O; Yamamoto T; Hirohashi K; Tanaka H; Tanaka S; Hai S; Ono K; Kubo S
    J Hepatobiliary Pancreat Surg; 2006; 13(3):239-44. PubMed ID: 16708302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma.
    Hashimoto K; Ikeda Y; Korenaga D; Tanoue K; Hamatake M; Kawasaki K; Yamaoka T; Iwatani Y; Akazawa K; Takenaka K
    Cancer; 2005 May; 103(9):1856-64. PubMed ID: 15779015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.